Pharmaceutical Grade Sodium Chloride Market

Pharmaceutical Grade Sodium Chloride Market Size Analysis

According to a recent survey conducted by ChemView Consulting, the Global Pharmaceutical Grade Sodium Chloride Market grew at a CAGR of 5.6% between 2017-2021 and is estimated to be US$ 379.8 Mn in 2022. Currently, the market is anticipated to grow at a CAGR of 6.5% and is expected to reach a valuation of US$ 712.9 Mn by 2032 end.

Common salt, also known as sodium chloride, is employed in several sectors, including the cosmetic, pharmaceutical, and processed food industries. Dialysis or kidney transplants are used to treat end-stage renal disease (ESRD) patients.

However, compared to the frequently used dialysis operation, the rate of kidney transplants is relatively low because there are not enough kidney donors available, in addition to several other medical conditions.

Market Dynamic

THE ADVANCEMENTS IN MATRIX TABLETS PROPEL DEMAND FOR SODIUM CHLORIDE

Oral drug delivery has generated superior outcomes for manufacturers and end-users as a route of drug administration because of its high patient compliance, cost-effectiveness, lower sterility, constraints, flexibility in the design of dosage forms, and ease of production. The need for matrix tablets is crucial for controlled and sustained-release dosage forms. Matrix pills are frequently made using sodium chloride of the pharmaceutical grade.

The need for innovation and research will be fueled by the ongoing rise in stress- and lifestyle-related disorders among Indians, leading to the creation of novel drug-delivery technologies. As a result, the market for innovative drug formulations will expand.

STRINGENT GOVERNMENT REGULATIONS AND CERTIFICATIONS ARE EXPECTED TO OBSTRUCT THE MARKET GROWTH

It is anticipated that stringent government restrictions, certifications, and low profitability will impede industry expansion. The pharmaceutical-grade sodium chloride market is expected to have difficulties developing new technologies and advancements over the forecast period.

THE HIGH SPENDING CAPACITY OF PEOPLE IN DEVELOPING COUNTRIES IS EXPECTED TO CONTINUE TO OPEN UP LUCRATIVE BUSINESS OPPORTUNITIES

It is anticipated that both established market players and recent entrants will benefit from the high purchasing power of consumers in developing nations and the rising demand for pure, certified salt. The pharmaceutical-grade sodium chloride market is anticipated to expand through several joint ventures and expansions, as well as increased demand from injections, dialysis, and pharmaceutical formulations.

Market Segments Covered in Report

By Type:

• API-NaCl
• HD-NaCl

By Application:

• Injections
• Hemodialysis
• Oral Rehydration Salts
• Osmotic Agents
• Others

By Region and Country:

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Rest of Asia-Pacific)
• Middle East (Saudi Arabia, Turkey, UAE, Rest of Middle East)
• Africa (South Africa, Nigeria, Egypt, Rest of Africa)

Segment-Wise Analysis

How will the growth of the growing demand for hemodialysis impact the pharmaceutical-grade sodium chloride market?

Over the projection period, the hemodialysis segment is anticipated to expand at a special rate of 5.9% CAGR. The application sector is expected to dominate the hemodialysis and hemofiltration solutions segment throughout the projection period. However, due to the rising use of salt in the manufacturing of pharmaceuticals, the saline drips, and API intermediates segments are anticipated to grow steadily.

Significant market traction is anticipated due to the pharmaceutical salt demand for the hemodialysis and hemofiltration solutions segment continuing to develop steadily. Pharmaceutical-grade sodium chloride use is expected to rise due to relatively increased rates of lifestyle-related illnesses, particularly in industrialized nations.

Region-Wise Analysis

The regions analyzed for the market include North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.

• Due to the availability and accessibility of the product in the region, Asia-Pacific is predicted to have the fastest expanding market, with a market share of 54.0% throughout the projection period.
• According to projections, North America will hold a sizeable portion of the world market for pharmaceutical-grade sodium chloride. Due to the enormous growth of the pharmaceutical business in North America, growth is anticipated to be steady. It is expected that the nation will make up around 6.1% of the North American region. The pharmaceutical-grade sodium chloride market is driven by a rise in demand from the local healthcare sector.

Competition Analysis

A shift in manufacturers’ priorities toward developing regions has been observed in the industry over the last few years. Several significant firms are also concentrating on raising their production capacity, introducing new goods, investing in R&D, and growing merger and acquisition activity.

A list of some of the key suppliers present in the market are:

• K + S AG
• AkzoNobel
• Cargill
• Hebei Huachen
• Swiss Saltworks
• Sudsalz Gmbh
• Tata Chemicals
• Cheetham Salt
• Salinen
• Dominion Salt Ltd.
• US Salt

Report Coverage and Highlights

• Our comprehensive, data-backed, and facts-oriented report provides niche and cross-sectional analysis at global and country levels.
• Assessment of the historical (actual data) and current market size (2017-2021), market projections (2022-2032), and CAGR.
• The market assessment across North America, Europe, East Asia, South Asia & Pacific, Latin America, Middle East, and Africa.
• Competitive tactical intelligence, key strategies adopted by top players, production capacity and company shares analysis, product brand surveys, and export-import analysis
• Pricing analysis to set and benchmark your current or future offerings across each product type helps you understand whether your pricing strategy is aligned with market expectations and can be compared to market disruptions.
• Predictions on critical supply and demand trends and technological expertise needed to address operations scalability.
• Consumer behavior shifts and their implications for players, list of end-users, and their consumption analysis.
• Key drivers, restraints, opportunities, and emerging trends impacting the market growth.
• Value chain analysis (list of manufacturers, distributors, end-users, and average profitability margins).
• Strategic market analysis, recommendations, and future headways on crucial winning strategies.